Damora Therapeutics, Inc.

DMRA · XNAS

CIK 1800315fmd_1DHVJPWZZKNHSK2C8T385MSKQ6Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2019 to Sep 30, 2026, 30 periods

Ratios computed from the standardized statements. Select a value to open its proof.